Nutriband acquires 4P Therapeutics
11 April 2018 -

Nutriband Inc (OTC: NTRB), a Nevada Corporation, has acquired 4P Therapeutics Inc, a transdermal drug delivery company, it was reported on Tuesday.

The deal is valued at a total of USD1,900,000 payable in both company stock and cash. 4P Therapeutics will receive 250,000 shares of common stock and a cash amount of USD400,000 and will now become the Pharmaceutical and Development unit of Nutriband Inc, with a specific focus on Transdermal and Topical Technologies, prescription drugs and clinical development.

Steven Damon, CEO of 4P Therapeutics, has been appointed to the Nutriband board of directors.